Clinical Trial Update: Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of azilsartan medoxomil in combination with chlorthalidone for moderate to severe essential hypertension; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Azilsartan Medoxomil (Edarbi) (azilsartan medoxomil)
• Chlorthalidone (chlorthalidone)

Snippet

Sponsor: Takeda | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2012-02-07